Lack of legal income is strongly associated with an increased risk of AIDS and death in HIV-infected injecting drug users

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 11, Issue 4, 1999, Pages 429-436

  Piketty, C ^a   Castiel, P ^a   Giral, P ^b   Lhomme, J P ^c   Boubilley, D ^c   Olievenstein, C ^c   Lert, F ^d   Kazatchkine, M D ^a  

^a HÔPITAL BROUSSAIS   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Hospital Marmottan   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CD4 ANTIGEN; OPIATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CELL COUNT; COHORT ANALYSIS; CONSULTATION; DEATH; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTPATIENT DEPARTMENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR; SOCIOECONOMICS; UNEMPLOYMENT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INCOME; MALE; MULTIVARIATE ANALYSIS; PARIS; RISK FACTORS; SOCIAL CLASS; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0032774810     PISSN: 09540121     EISSN: None     Source Type: Journal    
DOI: 10.1080/09540129947802     Document Type: Article

References (28)

1. Albaces, P., Schoenbaum, E.E. & Kleinn, R.S. (1993). Correlates of the rate ot decline of CD4 + lymphocytes among injection drug users infected with human immunodeficiency virus. American Journal of Epidemiology, 137, 989-1000.
2. Centers for Disease Control and Prevention (1992). 1993 revised classification system for HIV infection and expanded surveillance case for AIDS definition among adolescents and adults. MMWR, 41, 1-19, Atlanta.
3. Centers for Disease Control and Prevention (1993). HIV/AIDS Surveillance Report. October, 1-19.
4. Chaisson, R.E., Keruly, J.C. & Moore, R.D. (1995). Race, sex, and progression of human immunodeficiency virus disease. New England Journal of Medicine, 333, 751-756.
5. Delta Coordinating Committee (1996). Delta: a randomised double blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. The Lancet, 348, 283-291.
6. Des Jarlais, D.C., Friedman, S.R., Choopanya, K., Vanichsent, S. & Ward, T.P. (1992). International epidemiology of HIV and AIDS among injecting-drug users. AIDS, 6, 1053-1068.
7. Des Jarlais, D.C., Friedman, S.R., Marmor, M., Cohen, H., Mildvan, D., Yancovitz, S. et al. (1987). Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users. AIDS, 1, 105-111.
8. Easterbrook, P.J., Keruly, J.C., Creagh-Kirk, T., Richman, D.D., Chaisson, R.E., Moore, R.D. et al. (1991). Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease: zidovudine epidemiology study group. Journal of the American Medical Association, 266, 2713-2718.
9. Galai, N., Vlahov, D., Margolick, J.B., Chen, K., Graham, N.M.H. & Munoz, A. (1995). Changes in markers of disease progression in HIV-1 seroconverters: a comparison between cohorts of injecting drug users and homosexual men. Journal of Acquired Immune Deficiency Syndrome, 8, 66-74.
10. Kitayaporn, D., Tansuphaswadikul, S., Lohsomboom, P., Pannachet, K., Kaewkungwal, J., Limpakarnjanarat, K. & Mastro, T.D. (1995). Survival of AIDS patients in the emerging epidemic in Bangkok, Thailand. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 11, 77-82.
11. Lyles, C.M., Margolick, J.B., Astemborski, J., Graham, N.M.H., Anthony, J.C., Hoover, D.R. et al. (1997). The influence of drug use patterns on the rate of CD4 + lymphocyte decline among IIIV-1-infected injecting drug users. AIDS, 11, 1255-1262.
12. Margolick, J.B., Munoz, A., Vlahov, D., Solomon, L., Astemborski, J., Cohn, S. et al. (1992). Changes in T-lymphocytes subsets in intravenous drug users with HIV infection. Multicenter AIDS cohort study. Journal of the American Medical Association, 267, 1631-1636.
13. Mientjes, G.H., Van Ameijden, E.J., Van Den Hoek, A.J. & Coutinho, R.A. (1992). Increasing morbidity without rise in non-AIDS mortality among HIV-infected intravenous drug users in Amsterdam. AIDS, 6, 207-212.
14. Montella, F., Disora, F., Perucci, C.A., Abeni, D.D. & Recchia, O. (1992). T-lymphocytes subsets in intravenous drug users with HIV-1 infection. Journal of the American Medical Association, 268, 2516-2517.
15. Moore, R.D., Hidalgo, J., Sugland, B.W. & Chaisson, R.E. (1991). Zidovudine and the natural history of the acquired immunodeficiency syndrome. New England Journal of Medicine, 324, 1412-1416.
16. O'Connor, P.G., Selwyn, P.A. & Schottenfeld, R.S. (1994). Medical care for injection-drug users with human immunodeficiency virus infection. New England Journal of Medicine, 331, 450-459.
17. Pehrson, P., Lindback, S., Lindman, C., Gaines, H. & Giesecke, J. (1997). Longer survival after HIV infection for injecting drug users than for homosexual men: implications for immunology. AIDS, 11, 1007-1012.
18. Philips, A.N., Pezzotti, P., Lepri, A.C., Rezza, G. and the Italian Seroconversion Study (1994). CD4 count as a determinant of the time from HIV seroconversion to AIDS and death from AIDS: evidence from the Italian seroconversion study. AIDS, 8, 1299-1305.
19. Piette, J.D., Intrator, O., Zierler, S., Mor, V. & Stein, M.D. (1995). An exploratory analysis of survival with AIDS using a non parametric tree-structured approach. Epidemiology, 3, 310-318.
20. Ronald, P.J.M., Robertson, J.K. & Elton, R.A. (1994). Continued drug use and other cofactors for progression to AIDS among injecting drug users. AIDS, 8, 339-343.
21. Schechter, M.T., Hogg, R.S., Aylward, B., Craib, K.J.P., Le, T.N. & Montaner, J.S.G. (1994). Higher socioeconomic status is associated with slower progression of HIV infection independent of access to health care. Journal of Clinical Epidemiology, 47, 59-67.
22. Schneider, M.M.E., Hopelman, A.I.M., Eeftinck Schattenkerk, J.K.M., Nielsen, T.L., Van Der Graaf, Y., Frissen, J.P., et al. (1992). A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. New England Journal of Medicine, 327, 1836-1841.
23. Schobenbaum, E.E., Hartel, D., Selwyn, P.A., Klein, R.S., Davenny, K., Rogers, M. et al. (1989). Risk factors for human immunodeficiency virus infection in intravenous drug users. New England Journal of Medicine, 321, 874-879.
24. Selwyn, P.A., Alcabes, P., Hartel, D., Bueno, D., Schoenbaum, E.E., Klein R.S. et al. (1992). Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. New England Journal of Medicine, 327, 1697-1703.
25. Van Haastrecht, H.J., Van Den Hoek, A.J. & Coutinho, R.A. (1994). High mortality among HIV-infected injecting drug users without AIDS diagnosis: implications for HIV infection epidemic modelers? AIDS, 8, 363-366.
26. Von Overbeck, J., Egger, M., Smith, G.D., Schoep, M., Ledergerber, B., Furrer, H., et al. (1994). Survival in HIV infection: do sex and category of transmission matter? Swiss HIV cohort study. AIDS, 8, 1307-1313.
27. Weber, R., Ledergerber, B.,Opravil, M., Siegenthaler, W. & Luthy, R. (1990). Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone. British Medical Journal, 301, 1362-1365.
28. Zaccarelli, M., Gattari, P., Rezza, G., Conti, S., Spizzichino, L., Vlahof, D. et al. (1994). Impact of HIV infection on non AIDS mortality among Italian injecting drug users. AIDS, 8, 345-350.